TrialThe American journal of psychiatry2022

Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial.

Glenn-Milo Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.